Not recruitingISRCTN18346744
A study to evaluate the safety of NTX-1955 in patients with generalised anxiety disorder
Research studyAges 18–55United Kingdom
Understand this study
Who could participate?
This study is for people with anxiety. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
- Listed locations
- United Kingdom
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateNot clearly listed
- Recruitment status
- Not recruiting
- Enrollment listed in the registry
- Not clearly listed
- Sponsor
- Newleos Therapeutics
- Sponsor type
- Biotech company
- Study type
- Other
- Intervention type
- Other / unclear
- Locations
- United Kingdom
- Age range
- From 18 Years to 55 Years
- Official registry ID
- ISRCTN18346744
- Official title
Show the full official title
A study to evaluate the safety of NTX-1955 in patients with generalised anxiety disorder
Recruitment & locations
Not recruitingThis badge reflects the study status reported by the registry. Check the registry for the latest information.
United Kingdom
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Newleos Therapeutics.
Who can participate?
This study is for people with anxiety. Listed age limits: 18 years to 55 years. Other eligibility criteria apply.
Is this study still recruiting?
The registry lists this study as not recruiting.
Want to explore more studies?
Explore studiesRelated studies
Thirty-year follow-up of personality, anxiety and depression after earlier treatment
A before and after study to investigate the effectiveness of an individual psychological intervention in reducing anxiety and depression for heart failure patients
